Elanix Biotechnologies AG

  • WKN: A0WMJQ
  • ISIN: DE000A0WMJQ4
  • Land: Deutschland

Nachricht vom 13.05.2019 | 07:26

Elanix Biotechnologies AG: CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER CEO THOMAS J. SVOBODA ALONG WITH FURTHER TWO SUSPECTED ACCOMPLICES

Elanix Biotechnologies AG / Key word(s): Miscellaneous
Elanix Biotechnologies AG: CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER CEO THOMAS J. SVOBODA ALONG WITH FURTHER TWO SUSPECTED ACCOMPLICES

13-May-2019 / 07:26 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Ad Hoc English, 13 May 2019

ELANIX BIOTECHNOLOGIES AG: CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER CEO THOMAS J. SVOBODA ALONG WITH FURTHER TWO SUSPECTED ACCOMPLICES. FURTHERMORE, PROFESSOR LAURENT-APPLEGATE, FOUNDER AND INTERIM-CEO, ANNOUNCES TRANSFER OF SHARES IN ELANIX BIOTECHNOLOGIES AG.

 

Frankfurt, 13 May 2019 - Elanix Biotechnologies AG ("Elanix" or the "Company") has filed criminal charges against the former CEO Thomas J. Svoboda. Criminal charges will also be filed against two further accomplices of Mr. Svoboda.

Furthermore, Professor Laurent-Applegate, founder and Interim-CEO of Elanix, has announced that today, she has transferred a total of 1,038,609 shares of Elanix to Anja Silling (Chairman Of The Supervisory Board). This is equivalent to approximately 12.85 per cent of the Company's issued share capital. The purchase price is EUR 1.00 which is significantly below the current market price.

 

Lee Ann Laurent-Applegate

CEO

13-May-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Event im Fokus

Fachkonferenz Beteiligungsgesellschaften, 15.07.2020

Fachkonferenz Consumer / Leisure, 16.07.2020

Die Konferenzen finden aufgrund der aktuellen Situation nicht in den Räumen der Börse München statt, sondern als Online-Konferenz.

News im Fokus

BASF SE: BASF-Gruppe: operatives Ergebnis im 2. Quartal 2020 über Markterwartungen; Ergebnis nach Steuern und nicht beherrschenden Anteilen infolge einer vor allem öl- und gaspreisbedingten Wertberichtigung der Beteiligung Wintershall Dea unter Markterwar

10. Juli 2020, 14:27

Aktuelle Research-Studie

Original-Research: PAION AG (von First Berlin Equity Research GmbH): Kaufen PAION AG

09. Juli 2020